Endurant Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-151,820
Closed -$1.82M 69
2020
Q4
$1.82M Sell
151,820
-110,953
-42% -$1.31M 0.66% 43
2020
Q3
$2.63M Sell
262,773
-141,020
-35% -$1.7M 0.78% 37
2020
Q2
$4.22M Buy
403,793
+147,844
+58% +$1.64M 0.23% 25
2020
Q1
$2.74M Buy
255,949
+145,814
+132% +$1.77M 1.24% 21
2019
Q4
$1.74M Buy
110,135
+23,728
+27% +$254K 0.55% 36
2019
Q3
$677K Buy
+86,407
New +$768K 0.24% 44
2017
Q2
Sell
-14,600
Closed -$815K 98
2017
Q1
$815K Buy
+14,600
New +$767K 0.26% 70

Other funds holding PRTA

Endurant Capital Management's PRTA Position: Q1 2021 in Review

Endurant Capital Management sold out of Prothena Corp (PRTA) in Q1 2021, closing a stake of 151,820 shares — an estimated $1.82M sold.

Endurant Capital Management first reported a position in PRTA in Q1 2017 and held it in 7 quarters. The position peaked at $4.22M in Q2 2020. 146 funds tracked by Wall St. Rank hold PRTA as of Q1 2021.

  • Endurant Capital Management reported no remaining Prothena Corp position as of Q1 2021 after selling out during the quarter.
  • Endurant Capital Management sold 151,820 Prothena Corp shares in Q1 2021, an estimated $1.82M.
  • Endurant Capital Management first reported a position in Prothena Corp in Q1 2017 and held it in 7 quarters.
  • Endurant Capital Management's Prothena Corp position peaked at $4.22M in Q2 2020.
  • 146 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2021.

Based on Endurant Capital Management's 13F filing for Q1 2021, filed 17 May 2021.